Michael Wilkinson, MD, Assistant Professor of Medicine, is a cardiologist and lipidologist who leads the advanced lipid treatment program at UC San Diego Health.
Dr. Wilkinson’s research interests include lifestyle change and novel drug-therapies for patients who are at risk for cardiovascular disease, including those with cardiometabolic diseases and all forms of dyslipidemia, including elevated lipoprotein(a). He has received grant support for his research from the American College of Cardiology and National Institutes of Health, among other agencies.